LYOSPARK® Controlled Nucleation Technology
LYOSPARK® controlled nucleation technology from GEA facilitates uniform ice crystal formation in pilot and production-scale freeze dryers. This is reflected in more consistent and larger ice crystal sizes with a more open product structure. As a result, faster drying and reconstitution times can be achieved. In addition, LYOSPARK® ensures inter-batch homogeneity, improves process repeatability and enhances both the presentation and quality of the final product.
GEA.com
INTRODUCING LYOSPARK®: Revolutionizing Industrial Freeze Drying.
REVOLUTIONIZING INDUSTRIAL FREEZE DRYING.
The lyophilization process consists of three key stages: freezing, primary drying, and secondary drying. The nucleation of ice crystals, the initial step in ice formation during freezing, traditionally unfolds spontaneously and over an extended period. However, our innovative LYOSPARK® technology has changed the game by allowing for controlled nucleation at specific temperatures and rates, enhancing batch homogeneity and reducing cycle duration.
In the past, the random nature of nucleation made lyophilization a challenging process. For example, when filling pharmaceutical formulations in vials, crystals could form at temperatures ranging from -5 to -20 °C. The nucleation temperature directly influences the ice structure, crystal size, and the appearance of the dried product, impacting Critical Quality Attributes (CQAs) such as residual moisture and dissolution behavior.
GEA proudly presents a patented and proven technology that seamlessly integrates with our existing freeze dryers, eliminating the need for new pharmaceutical formulations. LYOSPARK® delivers a novel and scalable method for controlling the nucleation process.
Welcome to a groundbreaking approach to industrial freeze drying that simplifies the process, ensures reliability, and offers precise control over nucleation.
2 LYOSPARK® — Controlled Nucleation.
LYOSPARK® — SIMULTANEOUS CRYSTAL NUCLEATION.
Integrating LYOSPARK® technology into conventional freeze-drying processes is straightforward. Vials are loaded into the freeze dryer and cooled to the optimal nucleation/ cooling temperature. Once the nucleation temperature is reached, the chamber is vented with gas from the freeze dryer’s condenser.
A filter-equipped cooling trap is attached to the chamber, where ice crystals form on the cooled surface and are carried away in the gas stream during venting. Inside the supercooled product solution, these ice crystals trigger an immediate and homogeneous nucleation in each vial. The nucleation and the subsequent formation of ice crystals at higher temperatures results in larger pores, reducing drying times. LYOSPARK® offers superior scalability and higher throughput speeds, optimizing performance and productivity.
Process Optimization LYOSPARK® eliminates issues such as active ingredient denaturation and unpredictable scale-up. It offers numerous technical advantages, including enhanced product quality, consistent vial uniformity per batch, and, depending on the product, a more uniform, aesthetically pleasing cake.
LYOSPARK® is ideal for highly potent applications, as no toxic gas is released into the environment.
In summary, LYOSPARK® controlled nucleation technology streamlines ice crystal formation in production-scale freeze dryers with minimal supercooling, resulting in more consistent and larger ice crystal sizes, and a more open product structure. This translates to quicker drying and reconstitution times. Compliant with Quality by Design (QbD) standards, GEA’s LYOSPARK® offers uniform, high- quality products, reduced process times, and an economical solution for controlled nucleation.
Advantages at a Glance • �Larger ice crystals • �Shorter drying times • �Improved process control • �Enhanced reconstitution • �Reduced vial cracking • �Lower stress on biological agents
�Cost-efficient technology available as an option for all GEA freeze dryers, with retrofit upgrades for existing facilities.
FD Process without LYOSPARK® Nucleation Temperatures for 3 wt% Mannitol Solutions
FD Process with LYOSPARK® Nucleation Temperatures for 3 wt% Mannitol Solutions
With LYOSPARK®, you can precisely control the temperature at which nucleation crystals form within your product, ensuring uniform process conditions for every vial in the chamber, regardless of its position on the shelf.
FD Process Comparison with/without LYOSPARK®.
3 LYOSPARK® — Controlled Nucleation.
Further information GEA Pharma & Healthcare lyophil@gea.com gea.com/contact
4 LYOSPARK® — Controlled Nucleation.
https://www.youtube.com/GEAPharma https://www.linkedin.com/showcase/gea-pharma-&-healthcare/ https://www.facebook.com/GEAPharma
GEA.com
© GEA Lyophil GmbH 06/2026. All rights reserved. Subject to modifications. LYOSPARK® is registered as a trademark in several countries worldwide.
GEA Lyophil GmbH Siemensstrasse 9, 50189 Elsdorf, Germany
Tel +49 2274 93 80 99-0 lyophil@gea.com gea.com/contact